Basics Roivant Sciences Ltd. Common Shares IPO Date: January 1, 2021 Sector: Healthcare Industry: Biotech Market Cap: $14.58B Activated in VL: True Average Daily Range Avg Daily Range: $0.21 | 2.42% Avg Daily Range (30 D): $0.34 | 1.70% Avg Daily Range (90 D): $0.24 | 1.47% Institutional Daily Volume Avg Daily Volume: 2.95M Avg Daily Volume (30 D): 6.36M Avg Daily Volume (90 D): 6.21M Trade Size Avg Trade Size (Sh.): 149 Avg Trade Size (Sh.) (30 D): 135 Avg Trade Size (Sh.) (90 D): 150 Institutional Trades Total Inst.Trades: 3,260 Avg Inst. Trade: $3.64M Avg Inst. Trade (30 D): $5.15M Avg Inst. Trade (90 D): $4.47M Avg Inst. Trade Volume: .31M Avg Inst. Trades (Per Day): 4 Market Closing Trades Avg Closing Trade: $8.86M Avg Closing Trade (30 D): $19.5M Avg Closing Trade (90 D): $13.99M Avg Closing Volume: 774.29K     News Sep 17, 2025 @ 11:00 AM Roivant and Priovant Announce Positive Phase 3 VAL... Source: Roivant And Priovant Sep 16, 2025 @ 12:00 PM Imbria Pharmaceuticals Strengthens Leadership with... Source: Gina Mangiaracina Sep 4, 2025 @ 11:00 AM Pulmovant Receives Orphan Drug Designation in Japa... Source: Pulmovant Sep 3, 2025 @ 4:57 PM Immunovant Unveils Durability and Treatment-Free S... Source: Immunovant, Inc. Feb 20, 2025 @ 8:22 AM Will Moderna Stock Drop to $25? 1 Wall Street Anal... Source: Eric Volkman Financials   TTM Q2 2026 Q1 2026 Basic EPS $-.56 $-.17 $-.33 Diluted EPS $-.56 $-.17 $-.33 Revenue $ 20.33M $ 1.57M $ 2.17M Gross Profit $ $ $ Net Income / Loss $ -574.25M $ -166.04M $ -273.91M Operating Income / Loss $ -1150.5M $ -306.23M $ -284.92M Cost of Revenue $ $ $ Net Cash Flow $ -782.17M $ -2.66M $ -1477.87M PE Ratio